Individuals with mild initial COVID-19 exhibited significant but subclinical reductions in left ventricular ejection fraction and altered diastolic function compared to uninfected controls.
Observational (n=437)
No
Does mild initial COVID-19 illness cause subclinical cardiac abnormalities on transthoracic echocardiography compared to non-infected controls?
Mild COVID-19 illness is associated with statistically significant but clinically small subclinical differences in systolic and diastolic echocardiographic parameters compared to healthy controls.
Absolute Event Rate: 56% vs 59.5%
p-value: p=<0.001
The aim of this study was to evaluate the subclinical patterns and evolution of cardiac abnormalities via transthoracic echocardiography (TTE) in patients with mild initial COVID-19 illness. A total of 343 infected individuals (163 males; age 44 (interquartile range, IQR 35-52) years) years) underwent serial TTE assessments at a median of 109 (interquartile range (IQR), 77-177) and 327 (276-379) days after infection. Compared with those of non-COVID-19-infected controls (n = 94, male n = 49), baseline systolic (LVEF, TAPSE) and diastolic function (e', a', E/e') were significantly different in infected participants (p < 0.05 for all). Compared with baseline assessments, there was a reduction in global longitudinal strain (GLS) and an increase in the E wave, E/A ratio and E/e' at follow-up. At baseline, symptomatic participants had a lower LVEF and TAPSE and increased IVRT, e' and E/e'. At follow-up, symptomatic patients had a lower LV end-diastolic diameter (LVEDd). Symptoms were independently associated with E/e' at baseline (OR (95% CI) 1.45 (1.12-1.87), p = 0.005). Symptoms at follow-up were associated with LVEDd, measured either at baseline (OR: 0.91 (0.86, 0.96), p < 0.001) or follow-up (OR (95% CI) 0.91 (0.86-0.96), p < 0.001). There were significant associations for GLS and troponin and E/e' with CRP and NTproBNP at baseline. In the present cohort of COVID-19-infected individuals with mild initial illness, echocardiographic measurements revealed significant yet subclinical differences in systolic and diastolic function compared with controls, as well as between individuals with cardiac symptoms and those without. All the measured differences were small in magnitude and thus unlikely to be detectable clinically at the individual level.
Shchendrygina et al. (Thu,) conducted a observational in Mild initial COVID-19 (n=437). COVID-19 infection vs. Non-COVID-19-infected controls was evaluated on Left ventricular ejection fraction (LVEF) at baseline (p=<0.001). Individuals with mild initial COVID-19 exhibited significant but subclinical reductions in left ventricular ejection fraction and altered diastolic function compared to uninfected controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: